文献速递妇科产科

机会性输卵管切除术与早绝经指标:加拿大不列颠哥伦比亚队列研究

Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.
PubMed 文献 · Am J Obstet Gynecol · 2020-02-15

该队列研究纳入不列颠哥伦比亚2008-2014年≤50岁女性共41413例,比较机会性输卵管切除术与单纯子宫切除术或输卵管结扎。结果显示,机会性输卵管切除术未增加绝经相关就诊或激素替代治疗开药的风险,而双侧输卵管卵巢切除术则显著增加。

要点

  • 机会性输卵管切除术未增加绝经相关就诊风险(aHR 0.98,95%CI 0.88-1.09)。
  • 机会性输卵管切除术未增加激素替代治疗开药风险(aHR 0.82,95%CI 0.72-0.92)。
  • 双侧输卵管卵巢切除术显著增加绝经就诊和激素替代治疗风险。

核心结论

  • 机会性输卵管切除术未显示早绝经迹象,以绝经就诊和激素替代治疗开药为指标。

研究设计与样本

  • 回顾性队列研究,纳入2008-2014年加拿大不列颠哥伦比亚≤50岁女性共41413例。
  • 比较机会性输卵管切除术(子宫切除时或绝育时)与单纯子宫切除或输卵管结扎。
  • 采用Cox比例风险模型,调整其他妇科疾病、手术方式和年龄。

主要发现

  • 子宫切除加机会性输卵管切除术者绝经就诊aHR 0.98(95%CI 0.88-1.09)。
  • 绝育时机会性输卵管切除术者绝经就诊aHR 0.92(95%CI 0.77-1.10)。
  • 子宫切除加机会性输卵管切除术者激素替代治疗开药aHR 0.82(95%CI 0.72-0.92)。
  • 绝育时机会性输卵管切除术者激素替代治疗开药aHR 1.00(95%CI 0.89-1.12)。
  • 子宫切除加双侧输卵管卵巢切除术者绝经就诊aHR 1.95(95%CI 1.78-2.13),激素替代治疗开药aHR 3.80(95%CI 3.45-4.18)。

临床怎么用

  • 对于一般卵巢癌风险女性,机会性输卵管切除术未显示增加早绝经风险,可支持临床决策。

局限性

  • 随访时间有限,部分分析随访不足5年。
  • 以医生就诊和处方开药作为绝经指标,非直接激素测定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The fallopian tube may often be the site of origin for the most common and lethal form of ovarian cancer, high-grade serous ovarian cancer. As a result, many colleges of obstetrics and gynecology, which include the American College of Obstetricians and Gynecologists, are recommending surgical removal of the fallopian tube (bilateral salpingectomy) at the time of other gynecologic surgeries (particularly hysterectomy and tubal sterilization) in women at general population risk for ovarian cancer, collectively referred to as opportunistic salpingectomy. Previous research has illustrated no increased risk of complications after opportunistic salpingectomy. However, most studies that have examined potential hormonal consequences of opportunistic salpingectomy have had limited follow-up time and have focused on surrogate hormonal markers. OBJECTIVE: We examine whether there are differences in physician visits for menopause and filling a prescription for hormone replacement therapy among women who undergo opportunistic salpingectomy in the population of British Columbia, Canada. STUDY DESIGN: We identified all women who were ≤50 years old in British Columbia who underwent opportunistic salpingectomy from 2008-2014. We compared women who underwent opportunistic salpingectomy at hysterectomy with women who underwent hysterectomy alone and women who underwent opportunistic salpingectomy for sterilization with women who underwent tubal ligation. We used Cox Proportional hazards models to model time to physician visits for menopause and for filling a prescription for hormone replacement therapy. We calculated adjusted hazards ratios for these outcomes and adjusted for other gynecologic conditions, surgical approach, and patient age. We performed an age-stratified analysis (<40, 40-44, 45-49 years) and conducted a sensitivity analysis that included only women with ≥5 years of follow up. RESULTS: We included 41,413 women in the study. There were 6861 women who underwent hysterectomy alone, 6500 who underwent hysterectomy with opportunistic salpingectomy, 4479 who underwent hysterectomy with bilateral salpingo-oophorectomy, 18,621 who underwent tubal ligation, and 4952 who underwent opportunistic salpingectomy for sterilization. In women who underwent opportunistic salpingectomy, there was no difference in time to the first physician visit related to menopause for both women who underwent hysterectomy with opportunistic salpingectomy (adjusted hazard ratio, 0.98; 95% confidence interval, 0.88-1.09) and women who underwent opportunistic salpingectomy for sterilization (adjusted hazard ratio, 0.92; 95% confidence interval, 0.77-1.10). There was also no difference in time to filling a prescription for hormone replacement therapy for women who underwent hysterectomy with opportunistic salpingectomy or opportunistic salpingectomy for sterilization (adjusted hazard ratio, 0.82; 95% confidence interval, 0.72-0.92; and adjusted hazard ratio, 1.00; 95% confidence interval, 0.89-1.12; respectively). In contrast, we report significantly increase hazards for time to physician visit for menopause (adjusted hazard ratio, 1.95; 95% confidence interval, 1.78, 2.13) and filling a prescription for hormone replacement therapy (adjusted hazard ratio, 3.80; 95% confidence interval, 3.45, 4.18) among women who underwent hysterectomy with bilateral salpingo-oophorectomy. There were no increased hazards for physician visits for menopause or initiation of hormone replacement therapy among women who underwent opportunistic salpingectomy in any of the age-stratified analyses, nor among women with at least 5 years of follow up. CONCLUSION: Our results reveal no indication of an earlier age of onset of menopause among the population of women who underwent hysterectomy with opportunistic salpingectomy and opportunistic salpingectomy for sterilization as measured by physician visits for menopause and initiation of hormone replacement therapy. Our findings are reassuring, given that earlier age at menopause is associated with increased mortality rates, particularly from cardiovascular disease.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Hanley GE, Kwon JS, McAlpine JN, et al. Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada. Am J Obstet Gynecol. 2020. PMID: 32067967. doi:10.1016/j.ajog.2020.02.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。